Clinical Trial Update: A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 study at MD Anderson Cancer Center is using 18F-FS PG PET imaging to guide therapy for hepatocellular carcinoma. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING